about
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road aheadAerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosisNew and emerging antifungal agents: impact on respiratory infections.Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.Safety of aerosolized amphotericin B.Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B.Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis.Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsAerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice.Model of recurrent pulmonary aspergillosis in rats.Aerosolized Delivery of Antifungal AgentsUse of amphotericin B aerosols for the prevention of pulmonary aspergillosis.Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.Inactivity of terbinafine in a rat model of pulmonary aspergillosis.
P2860
Q26822988-7B6EAD8E-59F4-4300-B056-3436E081F77BQ33749615-3E908AB7-2150-4A2E-A7AF-1B0F37A8845DQ33883785-0AAC3053-CD6C-47EE-A69F-4A1DA8BD51E8Q35627629-C4A3C31D-0FDE-4764-8972-DEA63CE1CD53Q36549164-225FDB66-88EC-4BA5-844F-FDA13787A9EEQ36945011-01B6E694-F917-494E-82E5-B93A1B5BA3FAQ39557905-3DEB4A5A-9458-4979-BC7D-3A454BA5F8BFQ39783583-1764937B-C6BF-4DBF-B0C8-0D755F96D846Q39866214-50ACF3CF-CF42-4133-B34E-4DA1155F9DCDQ39866778-601CB1C7-DA18-4D73-A687-25721C0D8879Q39879675-C526F76F-9441-4FDA-A274-886978EC304DQ40212850-9C8A92B0-840F-4DCC-975F-F7766278F8CDQ40522508-BD3A292A-9C95-4CA5-89C9-B932B92F868EQ40695013-713545C5-8A32-465F-86E1-21F5728E9B29Q41966523-FBBCB10E-D76D-460B-B90E-4AA84F4C0821Q42185615-4622E6B4-E393-487C-B76A-A0CA6D355B86Q46690197-45972F5F-4E7C-456C-931F-B0A64E473F20
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Pharmacokinetics of aerosol amphotericin B in rats.
@en
Pharmacokinetics of aerosol amphotericin B in rats.
@nl
type
label
Pharmacokinetics of aerosol amphotericin B in rats.
@en
Pharmacokinetics of aerosol amphotericin B in rats.
@nl
prefLabel
Pharmacokinetics of aerosol amphotericin B in rats.
@en
Pharmacokinetics of aerosol amphotericin B in rats.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of aerosol amphotericin B in rats.
@en
P2093
P2860
P356
10.1128/AAC.34.1.29
P407
P577
1990-01-01T00:00:00Z